TB Guidelines

Drug-Resistant TB (MDR TB) MMWR
Title	Format	Date Published
Treatment of Drug-Resistant Tuberculosis American Journal of Respiratory and Critical Care Medicine, 2019 Full Guidelinesexternal icon	Executive Summary PDFpdf icon -731 KB Full Guidelines PDFpdf icon – 1 MB	9/1/2019
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis MMWR 2013; 62 (No. 9)	PDFpdf icon (411 KB)	10/1/2013
Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013 MMWR 2013; 62 (No. 41)	PDFpdf icon (275 KB)	10/1/2013
Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States	PDFpdf icon (349 KB)	11/1/2008
Plan to Combat Extensively Drug-Resistant Tuberculosis MMWR 2009; 58 (RR-03)	PDFpdf icon (752 KB)	2/1/2009
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR-6)	PDFpdf icon (350 KB)	6/1/2000

Page last reviewed: October 23, 2020